Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,682 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner.
Gertz M, Adams D, Ando Y, Beirão JM, Bokhari S, Coelho T, Comenzo RL, Damy T, Dorbala S, Drachman BM, Fontana M, Gillmore JD, Grogan M, Hawkins PN, Lousada I, Kristen AV, Ruberg FL, Suhr OB, Maurer MS, Nativi-Nicolau J, Quarta CC, Rapezzi C, Witteles R, Merlini G. Gertz M, et al. Among authors: adams d. BMC Fam Pract. 2020 Sep 23;21(1):198. doi: 10.1186/s12875-020-01252-4. BMC Fam Pract. 2020. PMID: 32967612 Free PMC article.
Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin.
Valleix S, Gillmore JD, Bridoux F, Mangione PP, Dogan A, Nedelec B, Boimard M, Touchard G, Goujon JM, Lacombe C, Lozeron P, Adams D, Lacroix C, Maisonobe T, Planté-Bordeneuve V, Vrana JA, Theis JD, Giorgetti S, Porcari R, Ricagno S, Bolognesi M, Stoppini M, Delpech M, Pepys MB, Hawkins PN, Bellotti V. Valleix S, et al. Among authors: adams d. N Engl J Med. 2012 Jun 14;366(24):2276-83. doi: 10.1056/NEJMoa1201356. N Engl J Med. 2012. PMID: 22693999 Free article.
Amyloid neuropathies.
Adams D, Lozeron P, Lacroix C. Adams D, et al. Curr Opin Neurol. 2012 Oct;25(5):564-72. doi: 10.1097/WCO.0b013e328357bdf6. Curr Opin Neurol. 2012. PMID: 22941262 Review.
Safety and efficacy of RNAi therapy for transthyretin amyloidosis.
Coelho T, Adams D, Silva A, Lozeron P, Hawkins PN, Mant T, Perez J, Chiesa J, Warrington S, Tranter E, Munisamy M, Falzone R, Harrop J, Cehelsky J, Bettencourt BR, Geissler M, Butler JS, Sehgal A, Meyers RE, Chen Q, Borland T, Hutabarat RM, Clausen VA, Alvarez R, Fitzgerald K, Gamba-Vitalo C, Nochur SV, Vaishnaw AK, Sah DW, Gollob JA, Suhr OB. Coelho T, et al. Among authors: adams d. N Engl J Med. 2013 Aug 29;369(9):819-29. doi: 10.1056/NEJMoa1208760. N Engl J Med. 2013. PMID: 23984729 Free article. Clinical Trial.
Current and future treatment of amyloid neuropathies.
Adams D, Cauquil C, Theaudin M, Rousseau A, Algalarrondo V, Slama MS. Adams D, et al. Expert Rev Neurother. 2014 Dec;14(12):1437-51. doi: 10.1586/14737175.2014.983905. Epub 2014 Nov 21. Expert Rev Neurother. 2014. PMID: 25416603 Review.
Evolving landscape in the management of transthyretin amyloidosis.
Hawkins PN, Ando Y, Dispenzeri A, Gonzalez-Duarte A, Adams D, Suhr OB. Hawkins PN, et al. Among authors: adams d. Ann Med. 2015;47(8):625-38. doi: 10.3109/07853890.2015.1068949. Epub 2015 Nov 27. Ann Med. 2015. PMID: 26611723 Free PMC article. Review.
Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP.
Parman Y, Adams D, Obici L, Galán L, Guergueltcheva V, Suhr OB, Coelho T; European Network for TTR-FAP (ATTReuNET). Parman Y, et al. Among authors: adams d. Curr Opin Neurol. 2016 Feb;29 Suppl 1(Suppl 1):S3-S13. doi: 10.1097/WCO.0000000000000288. Curr Opin Neurol. 2016. PMID: 26734951 Free PMC article. Review.
5,682 results